SCHEMBL25852191

SCHEMBL25852191

CCC1(CC)OC(c2ccc3c(N)ccnn23)[C@H](OCc2ccccc2)[C@@H]1C

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ DHFR P00374 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25852194 1.00 DHFR (0.31) DHFR
SCHEMBL25852259 0.86 POLRMT (0.36) DHFR
SCHEMBL18371669 0.76 POLRMT (0.35) DHFR
SCHEMBL16708502 0.76 POLRMT (0.35) DHFR
SCHEMBL25852146 0.75 DHFR (0.31) DHFR
SCHEMBL16708521 0.74 POLRMT (0.34) —
SCHEMBL18371672 0.74 POLRMT (0.34) —
SCHEMBL25300989 0.69 POLRMT (0.38) —
SCHEMBL25254465 0.69 POLRMT (0.38) —
SCHEMBL25853155 0.69 POLRMT (0.38) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11697666-B2 Methods of preparing carbanucleosides using amides GILEAD SCIENCES, INC. (US) 2023-07-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11697666-B2 Methods of preparing carbanucleosides using amides NCL, DUT, POLN DHFR 2359/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback